Recombinant Sars Nucleocapsid Protein

SARS Nucleocapsid

ant-180 5µg
EUR 175
Description: Polyclonal Rabbit Anti SARS Nucleocapsid Protein

Human IgG antibody Laboratories manufactures the recombinant sars nucleocapsid protein reagents distributed by Genprice. The Recombinant Sars Nucleocapsid Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Recombinant. Other Recombinant products are available in stock. Specificity: Recombinant Category: Sars Group: Nucleocapsid Protein

SARS-CoV Nucleocapsid Protein

1 mg
EUR 2030.4

SARS-CoV Nucleocapsid Protein

1 mg
EUR 2030.4

SARS Nucleocapsid PT3851

100µg
EUR 900
Description: Mouse Anti SARS Nucleocapsid Clone PT3851

SARS Nucleocapsid Biotin

100µg
EUR 900
Description: Mouse Anti SARS Nucleocapsid Biotinylated

SARS Nucleocapsid HRP

100µg
EUR 900
Description: Mouse Anti SARS Nucleocapsid Horseradish Peroxidase

SARS-CoV Nucleocapsid Recombinant Protein

0.1 mg
EUR 752.1
Description: Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology; 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 Antibody (Nucleocapsid)

100 ug
EUR 390.15
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined. The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The nucleocapsid phosphoprotein is a structural protein that binds to, protects the viral RNA genome and is involved in packaging the RNA into virus particles. The N protein has been suggested as an antiviral drug target.

Nucleocapsid Protein information

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

20-229 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant protein

39-113 0.05 mg
EUR 556.8
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

97-077 0.1 mg
EUR 821.4
Description: Nucleocapsid protein is a most abundant protein of coronavirus. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. While screening for ADP-ribosylated proteins during coronavirus (CoV) infection, we identified as the viral nucleocapsid (N) protein. Novel post-translation modification of the CoV N protein that may play a regulatory role for this important structural protein. The array of diverse functional activities accommodated in the hantaviral N protein goes far beyond to be a static structural protein and makes it an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

97-085 0.1 mg
EUR 789.9
Description: Nucleocapsid protein is a most abundant protein of coronavirus. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. While screening for ADP-ribosylated proteins during coronavirus (CoV) infection, we identified as the viral nucleocapsid (N) protein. Novel post-translation modification of the CoV N protein that may play a regulatory role for this important structural protein. The array of diverse functional activities accommodated in the hantaviral N protein goes far beyond to be a static structural protein and makes it an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

92-728 1 mg
EUR 1023
Description: Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

Recombinant (E.Coli) SARS-CoV Nucleocapsid (1-422)

RP-1416 10 ug
EUR 270

SARS-CoV-2 Nucleocapsid Core Recombinant protein Liquid

ICOV2NTCR100UG each
EUR 648
Description: SARS-CoV-2 Nucleocapsid Core Recombinant protein Liquid

SARS-CoV-2 Nucleocapsid Recombinant protein (422aa) His Tag

ICOV2NTRHIS5UG each
EUR 640
Description: SARS-CoV-2 Nucleocapsid Recombinant protein (422aa) His Tag

SARS-CoV-2 Nucleocapsid Recombinant Protein N-6His Tag

ICOV2NCPDRN6HIS1MG each
EUR 1257
Description: SARS-CoV-2 Nucleocapsid Recombinant Protein N-6His Tag

SARS-CoV-2 (COVID-19) Nucleocapsid (N) Recombinant Protein

10-080 0.1 mg
EUR 619.8
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD). In both SARS-CoV and SARS-CoV-2, the CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells 3-5. The NTD of SARS-CoV-2 does not bind to ACE2 6, and the function of NTD in SARS-CoV-2 infection is not well understood. In other CoVs, the NTD may promote attachment by binding to sugar moieties 7 and might play a role in the conformational change of S2 required for membrane fusion 8. While most neutralizing antibodies target the RBD domain and block receptor binding, potent neutralizing antibodies targeting NTD were isolated from convalescent COVID19 patients 9, identifying the NTD as an attractive candidate for vaccines and therapeutics. In addition, the NTD is a promising antigen for diagnostic tests, as there is only 53.5% homology between the NTD of SARS-CoV-2 and SARS-CoV 10.

SARS Coronavirus Nucleocapsid Core Recombinant protein (340-390 aa)

39-120 0.1 mg
EUR 537.9
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

SARS-CoV-2 Nucleocapsid Mosaic Recombinant protein His Tag

ICOV2NTMOSAICRHIS50UG each
EUR 648
Description: SARS-CoV-2 Nucleocapsid Mosaic Recombinant protein His Tag

SARS Coronavirus Nucleocapsid Core Recombinant protein (1-49 aa)

39-119 0.1 mg
EUR 556.8
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

SARS-CoV-2 Nucleocapsid Recombinant protein (1-49 aa) Liquid

ICOV2NTR50UG each
EUR 648
Description: SARS-CoV-2 Nucleocapsid Recombinant protein (1-49 aa) Liquid

SARS-CoV-2 Nucleocapsid Recombinant protein (340-390 aa) His Tag

ICOV2NT340390AARHIS50UG each
EUR 648
Description: SARS-CoV-2 Nucleocapsid Recombinant protein (340-390 aa) His Tag

SARS-CoV-2 (COVID-19) Nucleocapsid Mosaic Recombinant protein

39-115 0.05 mg
EUR 556.8
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

Recombinant SARS-CoV Nucleocapsid [GST] (aa 1-49)

VAng-Wyb8617-inquire inquire Ask for price
Description: SARS-CoV Nucleocapsid (aa 1-49), recombinant protein from E. coli, 1 mg/mL.